EUROPACORP (ALECP.PA) Fundamental Analysis & Valuation

EPA:ALECP • FR0010490920

Current stock price

0.379 EUR
+0.01 (+1.34%)
Last:

This ALECP.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ALECP.PA Profitability Analysis

1.1 Basic Checks

  • ALECP had negative earnings in the past year.
  • In the past year ALECP had a positive cash flow from operations.
  • Of the past 5 years ALECP 4 years were profitable.
  • Each year in the past 5 years ALECP had a positive operating cash flow.
ALECP.PA Yearly Net Income VS EBIT VS OCF VS FCFALECP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

  • With a Return On Assets value of -2.37%, ALECP is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -2.37%
ROE N/A
ROIC N/A
ROA(3y)-1.27%
ROA(5y)19.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALECP.PA Yearly ROA, ROE, ROICALECP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5K 10K 15K

1.3 Margins

  • Looking at the Gross Margin, with a value of 22.50%, ALECP is doing worse than 84.44% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ALECP has declined.
  • The Profit Margin and Operating Margin are not available for ALECP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.32%
GM growth 5Y-14.72%
ALECP.PA Yearly Profit, Operating, Gross MarginsALECP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ALECP.PA Health Analysis

2.1 Basic Checks

  • ALECP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ALECP has been increased compared to 1 year ago.
  • The number of shares outstanding for ALECP has been increased compared to 5 years ago.
  • The debt/assets ratio for ALECP has remained at the same level compared to a year ago.
ALECP.PA Yearly Shares OutstandingALECP.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ALECP.PA Yearly Total Debt VS Total AssetsALECP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • ALECP has an Altman-Z score of -2.37. This is a bad value and indicates that ALECP is not financially healthy and even has some risk of bankruptcy.
  • ALECP has a Altman-Z score of -2.37. This is amonst the worse of the industry: ALECP underperforms 84.44% of its industry peers.
  • ALECP has a debt to FCF ratio of 28.76. This is a negative value and a sign of low solvency as ALECP would need 28.76 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 28.76, ALECP is in line with its industry, outperforming 42.22% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 28.76
Altman-Z -2.37
ROIC/WACCN/A
WACC4.82%
ALECP.PA Yearly LT Debt VS Equity VS FCFALECP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M

2.3 Liquidity

  • A Current Ratio of 1.16 indicates that ALECP should not have too much problems paying its short term obligations.
  • The Current ratio of ALECP (1.16) is better than 66.67% of its industry peers.
  • A Quick Ratio of 1.16 indicates that ALECP should not have too much problems paying its short term obligations.
  • ALECP's Quick ratio of 1.16 is fine compared to the rest of the industry. ALECP outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
ALECP.PA Yearly Current Assets VS Current LiabilitesALECP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ALECP.PA Growth Analysis

3.1 Past

  • ALECP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.50%, which is quite impressive.
  • ALECP shows a small growth in Revenue. In the last year, the Revenue has grown by 1.89%.
  • ALECP shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -14.67% yearly.
EPS 1Y (TTM)48.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.6%
Revenue 1Y (TTM)1.89%
Revenue growth 3Y-3.65%
Revenue growth 5Y-14.67%
Sales Q2Q%21.22%

3.2 Future

  • Based on estimates for the next years, ALECP will show a very negative growth in Earnings Per Share. The EPS will decrease by -38.96% on average per year.
  • The Revenue is expected to decrease by -35.46% on average over the next years. This is quite bad
EPS Next Y-49.12%
EPS Next 2Y-38.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-53.15%
Revenue Next 2Y-35.46%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALECP.PA Yearly Revenue VS EstimatesALECP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ALECP.PA Yearly EPS VS EstimatesALECP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

4

4. ALECP.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALECP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 8.31, the valuation of ALECP can be described as very reasonable.
  • ALECP's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALECP is cheaper than 95.56% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 37.39, ALECP is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 8.31
ALECP.PA Price Earnings VS Forward Price EarningsALECP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

  • ALECP's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ALECP is cheaper than 68.89% of the companies in the same industry.
  • ALECP's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ALECP is cheaper than 68.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.57
EV/EBITDA 5.99
ALECP.PA Per share dataALECP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2

4.3 Compensation for Growth

  • A cheap valuation may be justified as ALECP's earnings are expected to decrease with -38.96% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-38.96%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALECP.PA Dividend Analysis

5.1 Amount

  • No dividends for ALECP!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALECP.PA Fundamentals: All Metrics, Ratios and Statistics

EUROPACORP

EPA:ALECP (4/10/2026, 7:00:00 PM)

0.379

+0.01 (+1.34%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)12-11
Earnings (Next)05-26
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners13.1%
Ins Owner ChangeN/A
Market Cap47.53M
Revenue(TTM)33.99M
Net Income(TTM)-1.94M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.31
P/S 1.4
P/FCF 23.57
P/OCF 3.05
P/B N/A
P/tB N/A
EV/EBITDA 5.99
EPS(TTM)-0.02
EYN/A
EPS(NY)0.05
Fwd EY12.04%
FCF(TTM)0.02
FCFY4.24%
OCF(TTM)0.12
OCFY32.81%
SpS0.27
BVpS-0.03
TBVpS-0.29
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.37%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.5%
FCFM 5.93%
ROA(3y)-1.27%
ROA(5y)19.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.32%
GM growth 5Y-14.72%
F-Score5
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 28.76
Debt/EBITDA 2.53
Cap/Depr 74.8%
Cap/Sales 39.95%
Interest Coverage N/A
Cash Conversion 88.56%
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z -2.37
F-Score5
WACC4.82%
ROIC/WACCN/A
Cap/Depr(3y)110.61%
Cap/Depr(5y)70.32%
Cap/Sales(3y)61.29%
Cap/Sales(5y)38.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.6%
EPS Next Y-49.12%
EPS Next 2Y-38.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.89%
Revenue growth 3Y-3.65%
Revenue growth 5Y-14.67%
Sales Q2Q%21.22%
Revenue Next Year-53.15%
Revenue Next 2Y-35.46%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-31.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y132.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.59%
OCF growth 3Y0.62%
OCF growth 5Y-7.81%

EUROPACORP / ALECP.PA Fundamental Analysis FAQ

What is the fundamental rating for ALECP stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALECP.PA.


What is the valuation status for ALECP stock?

ChartMill assigns a valuation rating of 4 / 10 to EUROPACORP (ALECP.PA). This can be considered as Fairly Valued.


What is the profitability of ALECP stock?

EUROPACORP (ALECP.PA) has a profitability rating of 2 / 10.


What is the financial health of EUROPACORP (ALECP.PA) stock?

The financial health rating of EUROPACORP (ALECP.PA) is 3 / 10.